A better understanding of trial enrollment and results reported for specific demographic populations is likely to accelerate scientific progress and ultimately lead to more effective treatment options for all patients
Setting realistic expectations is crucial: weight loss is gradual, with clinical trials showing approximately 15% weight reduction with semaglutide 2.4 mg at 68 weeks and up to 21% with tirzepatide at 72 weeks, though individual responses vary considerably
However, it is noteworthy that incretin hormones may exert direct effects on pancreatic -cell function by reducing endoplasmic reticulum stress, enhancing autophagy, and preventing apoptosis [15,16]
If prescribed, youll receive guidance on how to use the medicationtypically a once-weekly injectionas well as ongoing support for nutrition, lifestyle, and behavioral changes
You want a team that understands how to combine energy support, medical oversight, and practical weight-loss guidance in a way that works in real life